demonstrated that insulin therapy itself might increase mortality in patients with COVID-19 and diabetes, remarking the shared biomarkers of increased plasma insulin and glucose in both obese and severe COVID-19 patients (153). The gene discussed is INS; the disease is diabetes mellitus.